PsyBio Therapeutics
(OTC) PSYBF
PsyBio Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$2.86M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.00
Volume
100
Open
$0.00
Price
$0.00
Volume
100
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.00
Volume
100
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
PSYBF News
PSYBF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PsyBio Therapeutics
PSYBF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
3%
Return on Assets
-13%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
100
Short Interest
0.00%
Avg. Volume
843.443
Financials (TTM)
Gross Profit
$50.00K
Operating Income
$4.34M
EBITDA
$4.53M
Operating Cash Flow
$3.44M
Capital Expenditure
$0.00
Free Cash Flow
$3.44M
Cash & ST Invst.
$848.00
Total Debt
$135.49K
PsyBio Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$25.00K
+0.0%
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
4
N/A
Net Income
$182.00K
+87.3%
EBITDA
$162.99K
+88.3%
Quarterly Fundamentals
Net Cash
$83.77K
-111.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$96.14K
-36.8%
Return on Assets
-12.52%
N/A
Return on Invested Capital
2.73%
N/A
Free Cash Flow
$339.60K
+126.0%
Operating Cash Flow
$339.60K
+126.0%